Acorah Software Products - Accounts Production 16.1.300 false true false 19 June 2023 30 June 2024 30 June 2024 14943900 Mr Yazid Jibrel iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14943900 2023-06-18 14943900 2024-06-30 14943900 2023-06-19 2024-06-30 14943900 frs-core:ShareCapital 2024-06-30 14943900 frs-core:RetainedEarningsAccumulatedLosses 2024-06-30 14943900 frs-bus:PrivateLimitedCompanyLtd 2023-06-19 2024-06-30 14943900 frs-bus:FilletedAccounts 2023-06-19 2024-06-30 14943900 frs-bus:SmallEntities 2023-06-19 2024-06-30 14943900 frs-bus:AuditExemptWithAccountantsReport 2023-06-19 2024-06-30 14943900 frs-bus:SmallCompaniesRegimeForAccounts 2023-06-19 2024-06-30 14943900 frs-bus:Director1 2023-06-19 2024-06-30 14943900 frs-countries:EnglandWales 2023-06-19 2024-06-30
Registered number: 14943900
Medical Ocean Ltd
Unaudited Financial Statements
For the Period 19 June 2023 to 30 June 2024
CJC Accountancy Ltd
Contents
Page
Accountant's Report 1
Balance Sheet 2
Notes to the Financial Statements 3
Page 1
Accountant's Report
Report of the Accountant to the director of Medical Ocean Ltd
These financial statements have been prepared in accordance with our terms of engagement and in order to assist you to fulfil your duties under the Companies Acts that relate to preparing the financial statements of the company for the period ended 30 June 2024.
We have prepared these financial statements based on the accounting records, information and explanations provided by you. We do not express any opinion on the financial statements.
On the Balance Sheet you have acknowledged your duties under the prevailing Companies Acts to ensure that the company keeps adequate accounting records and prepares financial statements that give “a true and fair view”.
You have determined that the company is exempt from the statutory requirement for an audit for this accounting period. Therefore, the financial statements are unaudited.
The financial statements are provided exclusively to the director for the limited purpose mentioned above, and may not be used or relied upon for any other purpose or by any other person, and we shall not be liable for any other usage or reliance.
Signed
07/02/2025
CJC Accountancy Ltd
124 City Road
London
EC1V 2NX
Page 1
Page 2
Balance Sheet
Registered number: 14943900
30 June 2024
Notes £ £
FIXED ASSETS
Intangible Assets 136,940
136,940
CURRENT ASSETS
Cash at bank and in hand 88
88
Creditors: Amounts Falling Due Within One Year (137,526 )
NET CURRENT ASSETS (LIABILITIES) (137,438 )
TOTAL ASSETS LESS CURRENT LIABILITIES (498 )
NET LIABILITIES (498 )
CAPITAL AND RESERVES
Called up share capital 4 1
Profit and Loss Account (499 )
SHAREHOLDERS' FUNDS (498)
For the period ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Yazid Jibrel
Director
07/02/2025
The notes on page 3 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Medical Ocean Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14943900 . The registered office is 86-90 Paul Street, London, EC2A 4NE.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Research and Development
In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research is recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised to ... on a straight line basis over their expected useful economic lives, which range from ... to ... years.
If it is not possible to distinguish between the research phase and the development phase of an internal project the expenditure is treated as if it were all incurred in the research phase only.
3. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
4. Share Capital
30 June 2024
£
Allotted, Called up and fully paid 1
Page 3